- Home
- TXG vs INMD Comparison
TXG vs INMD Comparison
Compare TXG & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- INMD
- Stock Information
- Founded
- TXG 2012
- INMD 2008
- Country
- TXG United States
- INMD Israel
- Employees
- TXG N/A
- INMD N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TXG Industrials
- INMD Health Care
- Exchange
- TXG Nasdaq
- INMD Nasdaq
- Market Cap
- TXG 1.5B
- INMD 1.5B
- IPO Year
- TXG 2019
- INMD 2019
- Fundamental
- Price
- TXG $10.90
- INMD $18.90
- Analyst Decision
- TXG Buy
- INMD Buy
- Analyst Count
- TXG 16
- INMD 5
- Target Price
- TXG $20.36
- INMD $22.25
- AVG Volume (30 Days)
- TXG 2.9M
- INMD 895.5K
- Earning Date
- TXG 02-12-2025
- INMD 02-04-2025
- Dividend Yield
- TXG N/A
- INMD N/A
- EPS Growth
- TXG N/A
- INMD N/A
- EPS
- TXG N/A
- INMD 2.25
- Revenue
- TXG $610,785,000.00
- INMD $394,818,000.00
- Revenue This Year
- TXG $4.38
- INMD $1.92
- Revenue Next Year
- TXG $9.08
- INMD $5.31
- P/E Ratio
- TXG N/A
- INMD $8.40
- Revenue Growth
- TXG N/A
- INMD N/A
- 52 Week Low
- TXG $10.80
- INMD $14.87
- 52 Week High
- TXG $48.42
- INMD $23.46
- Technical
- Relative Strength Index (RSI)
- TXG 24.63
- INMD 61.38
- Support Level
- TXG $11.43
- INMD $18.45
- Resistance Level
- TXG $13.12
- INMD $19.43
- Average True Range (ATR)
- TXG 0.98
- INMD 0.56
- MACD
- TXG -0.24
- INMD 0.10
- Stochastic Oscillator
- TXG 2.27
- INMD 83.01
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.